Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Royalty Pharma plc - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
RPRX
Nasdaq
2830
www.royaltypharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Royalty Pharma plc
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
- May 12th, 2026 2:15 pm
Income Investors Should Know That Royalty Pharma plc (NASDAQ:RPRX) Goes Ex-Dividend Soon
- May 11th, 2026 10:12 am
Why One Fund’s $4 Million Centerra Gold Exit Looks Like Profit-Taking Amid a 150% Rally
- May 10th, 2026 9:22 am
This Fund Cashed Out of Preformed Line Products Amid a 150% Stock Surge
- May 8th, 2026 9:14 am
10% Of This Royalty Pharma Insider's Holdings Were Sold
- May 8th, 2026 8:00 am
Royalty Pharma to present at upcoming investor conferences
- May 7th, 2026 2:15 pm
Royalty Pharma Q1 Earnings Call Highlights
- May 6th, 2026 2:42 pm
Royalty Pharma plc Q1 2026 Earnings Call Summary
- May 6th, 2026 11:07 am
RPRX vs. AMGN: Which Stock Is the Better Value Option?
- May 6th, 2026 9:40 am
Royalty Pharma PLC (RPRX) Hit a 52 Week High, Can the Run Continue?
- May 6th, 2026 7:15 am
Royalty Pharma (RPRX) Q1 Earnings and Revenues Surpass Estimates
- May 6th, 2026 7:05 am
Royalty Pharma reports first quarter 2026 results
- May 6th, 2026 5:00 am
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
- May 1st, 2026 7:00 am
Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
- Apr 30th, 2026 8:00 am
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Apr 29th, 2026 8:00 am
A Look At Royalty Pharma (RPRX) Valuation After Its Recent Share Price Momentum
- Apr 27th, 2026 2:04 am
Zymeworks Highlights Royalty-Fueled Pivot at Bloom Burton, Eyes Multibillion-Dollar Ziihera
- Apr 26th, 2026 1:12 am
3 Unpopular Stocks We’re Skeptical Of
- Apr 22nd, 2026 1:33 pm
Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation
- Apr 21st, 2026 11:00 am
Why Royalty Pharma Plc (RPRX) is One of the Most Undervalued Biotech Stocks to Buy Right Now
- Apr 19th, 2026 6:07 pm
Scroll